Literature DB >> 8870351

Reproducibility of ambulatory esophageal pH monitoring in the aperistaltic esophagus.

J P Shoenut1, A B Mieflikier, T A Aldor, C S Yaffe, D J Goldenberg.   

Abstract

The reproducibility of ambulatory 24-h esophageal pH monitoring was evaluated in 16 consecutive patients by comparing the difference in two consecutive 24-h periods. The study group included 8 patients with scleroderma esophagus and 8 treated achalasia patients. The amount of reflux was expressed as the percentage of time the pH was < 4.0. Both groups demonstrated excellent intrapatient reproducibility overall: 96% in scleroderma patients and 95% in those patients with achalasia. The least concordance was found in the lengths of the longest reflux events-70% when supine in scleroderma patients and 59% when upright in patients with achalasia. There was no significant difference (p > 0.05) between day 1 and day 2 for either group of patients for any of the elements studied. These results indicate that intrapatient variability of gastroesophageal reflux in patients with scleroderma esophagus and treated patients with achalasia is very low and following therapeutic intervention, a high level of confidence can be placed in subsequent pH monitoring as an indicator of treatment effect.

Entities:  

Mesh:

Year:  1996        PMID: 8870351     DOI: 10.1007/bf00265209

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  21 in total

1.  Reproducibility of 24 hour oesophageal pH studies in infants.

Authors:  F J Hampton; U M MacFadyen; H Simpson
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

2.  Barrett's esophagus and achalasia. A case report.

Authors:  F I Lee; S V Bellary
Journal:  J Clin Gastroenterol       Date:  1991-10       Impact factor: 3.062

3.  Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

Authors:  J R Murphy; P McNally; P Peller; S S Shay
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

4.  Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.

Authors:  P Stentoft; L Hendel; S Aggestrup
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

5.  Reflux in untreated achalasia patients.

Authors:  J P Shoenut; A B Micflikier; C S Yaffe; B Den Boer; J M Teskey
Journal:  J Clin Gastroenterol       Date:  1995-01       Impact factor: 3.062

6.  Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters.

Authors:  G J Wiener; T M Morgan; J B Copper; W C Wu; D O Castell; J W Sinclair; J E Richter
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

7.  Nasal continuous positive airway pressure. A new treatment for nocturnal gastroesophageal reflux?

Authors:  P Kerr; J P Shoenut; R D Steens; T Millar; A B Micflikier; M H Kryger
Journal:  J Clin Gastroenterol       Date:  1993-12       Impact factor: 3.062

8.  Twenty four hour oesophageal acidity in achalasia before and after pneumatic dilatation.

Authors:  H L Smart; P N Foster; D F Evans; B Slevin; M Atkinson
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

9.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring.

Authors:  T R DeMeester; C I Wang; J A Wernly; C A Pellegrini; A G Little; P Klementschitsch; G Bermudez; L F Johnson; D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1980-05       Impact factor: 5.209

10.  The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole.

Authors:  J P Shoenut; J A Wieler; A B Micflikier
Journal:  Aliment Pharmacol Ther       Date:  1993-10       Impact factor: 8.171

View more
  1 in total

1.  Impact of ingested liquids on 24-hour ambulatory pH tests.

Authors:  J P Shoenut; D Duerksen; C S Yaffe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.